Dr. Cusin went to Medical School at the Universita degli Studi, in Milan, Italy, where she also completed a residency in Psychiatry.

Dr. Cusin was working as Psychiatrist in an inpatient unit and involved in research when in 2004 she decided to come to the U.S. for a Research Fellowship at Mass. General Hospital.

She decided to pursue further training in the U.S. and after completing the Adult Psychiatry Residency at MGH/McLean she joined the staff of the Depression Clinical & Research Program (DCRP), under the mentorship of Dr Maurizio Fava.

She is Associate Professor in Psychiatry at Harvard Medical School.

Dr. Cusin is the director and founder of the MGH Ketamine clinic for treatment-resistant depression. She also has an outpatient clinic at the DCRP and often performs consultations for patients with Treatment-Resistant Depression. She has expertise in ketamine, VNS and DBS. Finally, she is one of the clinicians in the ECT team at MGH and she is involved in numerous research studies on ketamine in treatment-resistant mood disorders at MGH.